97 related articles for article (PubMed ID: 10691094)
1. Soluble fibrin species in arterial thrombi.
Sandbaek G; Bjørnsen S; Sobel JH; Nieuwenhuizen W; Matsueda G; Brosstad F
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):1-5. PubMed ID: 10691094
[TBL] [Abstract][Full Text] [Related]
2. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting.
Grøn B; Filion-Myklebust C; Bjørnsen S; Haidaris P; Brosstad F
Thromb Haemost; 1993 Sep; 70(3):438-42. PubMed ID: 8259545
[TBL] [Abstract][Full Text] [Related]
3. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
[TBL] [Abstract][Full Text] [Related]
5. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
6. Catheter-directed intra-arterial thrombolysis: size of soluble fibrin(ogen) degradation products studied by electrophoresis and immunoblotting.
Sandbaek G; Bjørnsen S; Brosstad F
Blood Coagul Fibrinolysis; 1999 Jun; 10(4):189-95. PubMed ID: 10390118
[TBL] [Abstract][Full Text] [Related]
7. Clearance characteristics of des-AA fibrin and des-AABB fibrin, and thrombus-related uptake of des-AABB fibrin as compared to fibrinogen.
Nilsen DW; Brosstad F; Holm B; Kierulf P; Godal HC
Scand J Clin Lab Invest Suppl; 1985; 178():115-9. PubMed ID: 3867112
[TBL] [Abstract][Full Text] [Related]
8. Soluble crosslinked fibrin(ogen) polymers.
Selmayr E; Müller-Berghaus G
Thromb Haemost; 1985 Dec; 54(4):804-7. PubMed ID: 4089815
[TBL] [Abstract][Full Text] [Related]
9. Normal and fibrinaemic patient plasma contain high-molecular weight crosslinked fibrin(ogen) derivatives with intact fibrinopeptide A.
Grøn B; Bennick A; Nieuwenhuizen W; Brosstad F
Thromb Res; 1990 Jan; 57(2):259-70. PubMed ID: 2315888
[TBL] [Abstract][Full Text] [Related]
10. [The fibrin and plasma-protein content of human thrombi].
Jakab T; Haeberli A; Straub PW
Schweiz Med Wochenschr; 1979 Sep; 109(37):1389. PubMed ID: 482912
[TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of fibrin and fibrinogen in biological material.
Haeberli A; Straub PW
J Lab Clin Med; 1980 Aug; 96(2):258-66. PubMed ID: 6447180
[TBL] [Abstract][Full Text] [Related]
12. Self-assembly of soluble unlinked and cross-linked fibrin oligomers.
Rosenfeld MA; Leonova VB; Biryukova MI; Vasileva MV
Biochemistry (Mosc); 2011 Oct; 76(10):1155-63. PubMed ID: 22098241
[TBL] [Abstract][Full Text] [Related]
13. Fibrin degradation products. A review of structures found in vitro and in vivo.
Gaffney PJ
Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of self-assembly of soluble fibrin oligomers and the role of fibrinopeptides A and B in this process].
Rozenfel'd MA; Gershkovich KB; Kuznetsov DV; Meshkov BB; Gontar' ID
Mol Biol (Mosk); 1986; 20(4):1098-110. PubMed ID: 3762532
[TBL] [Abstract][Full Text] [Related]
15. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
16. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen A alpha and gamma-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease.
Shainoff JR; Valenzuela R; Urbanic DA; DiBello PM; Lucas FV; Graor R
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):499-503. PubMed ID: 1983461
[TBL] [Abstract][Full Text] [Related]
18. Early cross-linked fibrin in human plasma contains alpha-polymers with intact fibrinopeptide A.
Grøn B; Filion-Myklebust C; Bennick A; Nieuwenhuizen W; Matsueda GR; Brosstad F
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):731-6. PubMed ID: 1489895
[TBL] [Abstract][Full Text] [Related]
19. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
Botnar RM; Buecker A; Wiethoff AJ; Parsons EC; Katoh M; Katsimaglis G; Weisskoff RM; Lauffer RB; Graham PB; Gunther RW; Manning WJ; Spuentrup E
Circulation; 2004 Sep; 110(11):1463-6. PubMed ID: 15238457
[TBL] [Abstract][Full Text] [Related]
20. Fibrin subunits in venous and arterial thromboembolism.
Gaffney PJ; Brasher M; Lord K; Strachan CJ; Wilkinson AR; Kakkar VV; Scully MF
Cardiovasc Res; 1976 Jul; 10(4):421-6. PubMed ID: 133759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
